Skip to main content
. 2020 May;373(2):230–238. doi: 10.1124/jpet.119.262337

Fig. 6.

Fig. 6.

Effects of MJN110 on 66.1 cancer cell proliferation in vitro. BrdU assay was performed to better assess changes in proliferation of 66.1 cells in response to MJN110. (A) Across three concentrations tested, MJN110 significantly decreased the proliferation of 66.1 cells in vitro at the 10-µM dose. One-way ANOVA with Bonferroni post hoc correction. ***P < 0.001 (n = 8 animals per group). (B) Dose response curve was generated for MJN110 and compared with the CB2 agonist JWH015 and the alternative MAGL inhibitor KML29 to determine effects on cell proliferation in vitro. BrdU = 5-bromo-2'-deoxyuridine.